Using Oral and Intranasal Dosage Forms of Ketamine for Managing Treatment-Resistant Depression: A Review of the Literature
A lack of effective treatment for patients with treatment-resistant depression (TRD) has led to the evaluation of ketamine, an N-methyl- D-aspartate receptor antagonist. Despite the demonstrated short-term benefits of using intravenous (IV) ketamine, side effects and the difficulty in administering...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
University Library System, University of Pittsburgh
2016-07-01
|
Series: | International Journal of Medical Students |
Subjects: | |
Online Access: | http://ijms.info/IJMS/article/view/153 |